Navigation Links
Optimal Treatment Boosts Blacks' Lung Cancer Survival
Date:1/19/2009

Patients who received recommended care did better, regardless of race, study found

MONDAY, Jan. 19 (HealthDay News) -- Survival disparities between white and black patients with early-stage lung cancer disappear when black patients receive optimal therapy, according to a U.S. study that included nearly 18,000 patients.

Surgery to remove a portion of the lung (pulmonary resection) provides the best chance of a cure for patients with early-stage lung cancer.

"Black patients with early-stage lung cancer have lower five-year survival rates than white patients, and this difference in outcome has been attributed to lower rates of resection among black patients," wrote Dr. Farhood Farjah, of the University of Washington, Seattle, and colleagues. "Several potential factors underlying racial differences in the receipt of surgical therapy include differences in pulmonary function, access to care, refusal of surgery, beliefs about tumor spread on air exposure at the time of operation and the possibility of cure without surgery, distrust of the health care system and physicians, suboptimal patterns of patient and physician communication and health care system and provider biases."

Access to care is often considered the most important of the factors that affect racial disparities among lung cancer patients.

The study looked at nearly 18,000 patients (89 percent white and 6 percent black) who were diagnosed with lung cancer between 1992 and 2002 and recommended for pulmonary resection.

The researchers found that 69 percent of black patients had surgery, compared with 83 percent of white patients. Five-year survival rates were similar among both black and white patients who had surgery.

"Although these findings do not refute the likely roles of health care system and provider biases and patient characteristics as important causal factors underlying health disparities, the findings do suggest that other factors (i.e., distrust, perceptions and beliefs about lung cancer and its treatment and limited access to subspecialty care) may have a more dominant role in causing disparities than previously recognized," the study authors wrote.

"The implication of these findings is that interventions designed to narrow gaps in health care should target structured aspects of care, providers and patients and communities at risk for lung cancer and suboptimal care," the team added.

The researchers suggested that referral of all patients with potentially curable lung cancer for consideration of lung resection may help reduce racial disparities in survival.

The study was published in the January issue of the journal Archives of Surgery.

More information

The U.S. National Cancer Institute has more about lung cancer.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Jan. 19, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Optimal systemic and splanchnic hemodynamic state after living-donor liver transplantation
2. In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment
3. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
4. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
5. Do patients with inflammatory bowel disease receive optimal care?
6. Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts
7. Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health
8. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
9. Optimal Readings Selected to Present at CEDs 25th Annual Venture Conference
10. Medco, Healthways Launch Center for Health Action to Deliver Optimal Health(TM)
11. eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Optimal Treatment Boosts Blacks' Lung Cancer Survival 
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: